Last reviewed · How we verify
Cetylpyridinium Chloride Buccal Tablets
Cetylpyridinium chloride is a cationic antimicrobial agent that disrupts bacterial cell membranes and inhibits microbial growth in the oral cavity.
Cetylpyridinium chloride is a cationic antimicrobial agent that disrupts bacterial cell membranes and inhibits microbial growth in the oral cavity. Used for Oral antimicrobial therapy for minor oral infections and inflammation, Oral hygiene and antiseptic treatment.
At a glance
| Generic name | Cetylpyridinium Chloride Buccal Tablets |
|---|---|
| Sponsor | Peking University People's Hospital |
| Drug class | Quaternary ammonium antimicrobial agent |
| Target | Bacterial cell membrane |
| Modality | Small molecule |
| Therapeutic area | Oral/Dental |
| Phase | FDA-approved |
Mechanism of action
Cetylpyridinium chloride (CPC) is a quaternary ammonium compound that acts as a broad-spectrum antimicrobial by binding to and disrupting bacterial cell membranes, leading to leakage of cellular contents and cell death. The buccal tablet formulation allows for prolonged local contact with oral tissues, providing sustained antimicrobial activity against oral pathogens. It is commonly used for oral hygiene and the treatment of minor oral infections and inflammation.
Approved indications
- Oral antimicrobial therapy for minor oral infections and inflammation
- Oral hygiene and antiseptic treatment
Common side effects
- Oral irritation or staining
- Taste disturbance
- Local allergic reaction
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |